Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2022-08-01 Transaction in Own Shar…
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
关于以集中竞价交易方式回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding the progress of the company's share repurchase program, detailing the number of shares repurchased, prices, and total funds used. It references the company's board meeting approving the repurchase plan and compliance with relevant regulations. The document does not contain financial statements or detailed financial analysis but is a status update on share buyback activities. Therefore, it fits the category of a Transaction in Own Shares (POS) filing, which covers reports of the company buying back its own shares.
2022-08-01 Chinese
关于以集中竞价交易方式首次回购公司股份的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from Shenzhen Huitai Medical Equipment Co., Ltd. regarding the company's first share repurchase through centralized bidding on the Shanghai Stock Exchange. It details the number of shares repurchased, prices, total funds used, and references the board meeting approving the repurchase plan. The document is focused on the company's share buyback activity and does not contain financial statements or earnings data. It is not a report or a presentation but a formal announcement of a transaction in the company's own shares. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length is short and specific to the repurchase event, confirming this classification with high confidence.
2022-07-08 Chinese
北京市嘉源律师事务所关于深圳惠泰医疗器械股份有限公司2022年第一次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, procedures, attendance, and voting results of the 2022 first extraordinary general meeting (临时股东大会) of Shenzhen Huitai Medical Device Co., Ltd. It details the legality and compliance of the meeting process, qualifications of attendees, and voting outcomes. It is not the actual shareholder meeting materials or minutes but a legal opinion on the meeting's conduct and results. This type of document is typically classified as a Regulatory Filing (RNS) because it is a legal compliance document related to a shareholder meeting, not the meeting presentation (AGM-R), voting results announcement (DVA), or management information (MANG). The document length is short (2764 characters) and it is a standalone legal opinion letter, not a full report or announcement of a report publication. Therefore, the best fit is Regulatory Filings (RNS).
2022-06-30 Chinese
2022年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2022 first extraordinary general meeting of shareholders of Shenzhen Huitai Medical Devices Co., Ltd. It includes information about the meeting date, attendance, voting results on various proposals, and legal witness statements. The content focuses on the voting outcomes and procedural details of a shareholders' meeting rather than presenting a full annual report, financial statements, or management discussion. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 2212 characters, which is typical for such announcements. Therefore, the correct classification is DVA with high confidence.
2022-06-30 Chinese
关于中证中小投资者服务中心《股东建议函》回复的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from Shenzhen Huitai Medical Equipment Co., Ltd. responding to a shareholder suggestion letter regarding the company's planned acquisition of a 37.33% stake in Shanghai Hongtong Industrial Co., Ltd. The content includes extensive explanations about the acquisition valuation, business prospects, and management considerations. It is not a financial report, earnings release, or regulatory certification. It is a regulatory announcement addressing shareholder concerns and company responses related to a specific transaction. There is no indication that this is a full annual or interim report, audit report, or earnings release. The document is longer than 5,000 characters and contains substantive content, so it is not a mere report publication announcement. The nature of the document fits best with a Regulatory Filing (RNS) as it is a formal company announcement responding to shareholder queries and explaining a transaction without fitting into other more specific categories.
2022-06-29 Chinese
关于以集中竞价交易方式回购股份的回购报告书
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement from Shenzhen Huitai Medical Equipment Co., Ltd. regarding a share repurchase plan through centralized bidding. It includes specifics about the purpose, amount, price, duration, funding source, board approval, risks, and impact analysis of the share buyback. The document also discusses the use of repurchased shares for employee stock ownership plans or equity incentives, and the potential cancellation of shares if not transferred within three years. It contains no financial statements or earnings data but focuses entirely on the share repurchase program and related disclosures. This matches the definition of a Transaction in Own Shares (POS) filing, which reports on company buybacks or sales of its own shares. The document is lengthy and substantive, not a brief announcement or a certification, so it is not RPA or RNS. Therefore, the correct classification is POS with high confidence.
2022-06-22 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.